Company Filing History:
Years Active: 1989
Title: **Innovative Contributions of Gordon A. Elger**
Introduction
Gordon A. Elger is an accomplished inventor based in Huntingdon, Great Britain. With a total of three patents to his name, Elger has made significant advancements in the pharmaceutical field, particularly in the development of controlled release medications.
Latest Patents
Elger's latest patents showcase his innovative approach to pharmaceutical compositions. One notable invention is a pharmaceutical composition that combines analgesic and anti-inflammatory properties. This unique formulation is designed as a multiphase tablet, featuring a narcotic analgesic phase, which may include codeine phosphate, and a non-steroidal anti-inflammatory phase, which may contain ibuprofen. Both phases are meticulously crafted to exclude certain substances, ensuring the efficacy and safety of the medication.
Additionally, Elger has secured a patent for a controlled release pharmaceutical composition. This composition integrates an active ingredient into a specialized matrix that includes water-soluble polydextrose and cyclodextrin, along with fatty alcohol and polyalkylene glycol. This development promises to enhance the controlled release of medications, improving patient outcomes.
Career Highlights
Gordon A. Elger currently works with Euro-Celtique S.A., where he plays a crucial role in drug formulation and development. His experience in pharmaceutical innovations positions him as a valuable asset to the company and the broader healthcare industry.
Collaborations
Throughout his career, Elger has collaborated with esteemed coworkers such as Stewart Thomas Leslie and Sandra Therese Malkowska. These partnerships have fostered an environment of creativity and shared knowledge, further driving innovation in their projects.
Conclusion
Gordon A. Elger's contributions to the field of pharmaceuticals through his patents illustrate the importance of innovation and collaboration in developing effective medical treatments. As he continues to advance his research and development efforts, the positive impact of his work is likely to resonate within the healthcare community and beyond.